172 related articles for article (PubMed ID: 21347689)
21. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.
Takamiya Y; Short MP; Ezzeddine ZD; Moolten FL; Breakefield XO; Martuza RL
J Neurosci Res; 1992 Nov; 33(3):493-503. PubMed ID: 1335091
[TBL] [Abstract][Full Text] [Related]
23. Construction of double suicide genes system controlled by MDR1 promoter with targeted expression in drug-resistant glioma cells.
Zhang Y; Wang CW; Wang ZG; Ma DX; Pan S; Zhu SG; Li F; Wang B
J Neurooncol; 2008 Jan; 86(1):3-11. PubMed ID: 17594053
[TBL] [Abstract][Full Text] [Related]
24. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
25. Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.
Tamura K; Tamura M; Ikenaka K; Yoshimatsu T; Miyao Y; Nanmoku K; Shimizu K
Gene Ther; 2001 Feb; 8(3):215-22. PubMed ID: 11313793
[TBL] [Abstract][Full Text] [Related]
26. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy.
Wang CY; Li F; Yang Y; Guo HY; Wu CX; Wang S
Cancer Res; 2006 Jun; 66(11):5798-806. PubMed ID: 16740719
[TBL] [Abstract][Full Text] [Related]
27. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB
J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663
[TBL] [Abstract][Full Text] [Related]
28. Bystander effect in glioma suicide gene therapy using bone marrow stromal cells.
Li S; Gu C; Gao Y; Amano S; Koizumi S; Tokuyama T; Namba H
Stem Cell Res; 2012 Nov; 9(3):270-6. PubMed ID: 23022734
[TBL] [Abstract][Full Text] [Related]
29. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
30. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
33. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S
Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy for human malignant brain tumors.
Rainov NG; Ren H
Cancer J; 2003; 9(3):180-8. PubMed ID: 12952303
[TBL] [Abstract][Full Text] [Related]
35. Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy.
Khan Z; Knecht W; Willer M; Rozpedowska E; Kristoffersen P; Clausen AR; Munch-Petersen B; Almqvist PM; Gojkovic Z; Piskur J; Ekström TJ
Neuro Oncol; 2010 Jun; 12(6):549-58. PubMed ID: 20154339
[TBL] [Abstract][Full Text] [Related]
36. Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy.
Pacholska A; Wirth T; Samaranayake H; Pikkarainen J; Ahmad F; Ylä-Herttuala S
Cancer Gene Ther; 2012 Dec; 19(12):870-4. PubMed ID: 23079672
[TBL] [Abstract][Full Text] [Related]
37. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
38. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
39. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
[TBL] [Abstract][Full Text] [Related]
40. Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors.
Zhao Y; Lam DH; Yang J; Lin J; Tham CK; Ng WH; Wang S
Gene Ther; 2012 Feb; 19(2):189-200. PubMed ID: 21633393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
